Back to REGN
Tamar Securities, LLC REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
6
Latest value
$27.1M
Q3 2026
Peak value
$31.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $18.1M |
| Q4 2025 | $31.2M |
| Q1 2026 | $27.2M |
| Q1 2026 | $77K |
| Q2 2026 | $23.1M |
| Q3 2026 | $27.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $27.1M | 35.8K | — | — |
| Q2 2026 | $23.1M | 37.1K | — | — |
| Q1 2026 | $77K | 100 | — | — |
| Q1 2026 | $27.2M | 35.2K | — | — |
| Q4 2025 | $31.2M | 40.5K | — | — |
| Q3 2025 | $18.1M | 32.3K | — | — |
Other funds holding REGN
$6.2B
$5.7B
$5.2B
$5.1B
$4.7B
$4.7B
$4.5B
$4.3B